Cite
MLA Citation
Michael Gnant et al.. “Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.” Lancet oncology, vol. 20, no. 3, 2019, pp. 339–351. http://access.bl.uk/ark:/81055/vdc_100077975614.0x000017